Why Eli Lilly & Co could be a recession-proof stock - BitcoinEthereumNews.com
Summary by Ground News
Elly Lilly & Co. sales are expected to compound at a 9% annually to $45 billion by 2027. The shares are up almost 20% year-to-date (YTD) on steadily increasing trading volumes. On April 28, the company announced its Q1 2022 earnings results, beating analysts' estimates.2 months ago
Time & Location
Sources are mostly out of (0)
Bias Distribution
No sources with tracked biases.
See less detail
